Effect of magnesium and vitamin D supplementation in the treatment of ADHD

Phase 1

• Conditions: attention deficit-hyperactivity disorder.; Disturbance of activity and attention; F 90.0

• Registration Number: IRCT2016030326886N1
• Lead Sponsor: Vice chancellor for research, Isfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 74

Inclusion Criteria

1) age between 6-12 year 2) signing informed written consents to participate in the study 4) serum 25-OH-vitamin D level less than 30 ng/dl 5) serum Mg level less than 2.3 mg/dl. Exclusion criteria: 1) Ages outside the above range 2) Unwillingness to participate in the study 3) having chronic medical diseases 4) serum 25-OH-vitamin D level more than 30 ng/dl and serum Mg level more than 2.3 mg/dl.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cognitive and behavioral function. Timepoint: before, 4 weeks and 8 weeks after intervention. Method of measurement: Conner's Parent Rating Scale (CPRS).;Cognitive and behavioral function. Timepoint: before, 4 weeks and 8 weeks after intervention. Method of measurement: Strength and Difficulties Questionnaire (SDQ).

Secondary Outcome Measures

Name	Time	Method
Serum vitamin D level. Timepoint: First and end of intervention(2 month). Method of measurement: ELISA.;Serum magnesium level. Timepoint: First and end of intervention(2 month). Method of measurement: spectrophotometry.